A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. [electronic resource]
Producer: 20130225Description: 506-10 p. digitalISSN:- 1095-6859
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Cohort Studies
- Docetaxel
- Fallopian Tube Neoplasms -- drug therapy
- Female
- Humans
- Infusions, Intravenous
- Injections, Intraperitoneal
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Peritoneal Neoplasms -- drug therapy
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.